miR-455 inhibits neuronal cell death by targeting TRAF3 in cerebral ischemic stroke
Authors:
Open Access
- 1 December 2016
- journal article
- research article
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 12, 3083-3092
Abstract
Ischemic stroke is one of the leading causes of brain disease, with high morbidity, disability, and mortality. MicroRNAs (miRNAs) have been identified as vital gene regulators in various types of human diseases. Accumulating evidence has suggested that aberrant expression of miRNAs play critical roles in the pathologies of ischemic stroke. Yet, the precise mechanism by which miRNAs control cerebral ischemic stroke remains unclear. In the present study, we explored whether miR-455 suppresses neuronal death by targeting TRAF3 in cerebral ischemic stroke. The expression levels of miR-455 and TRAF3 were detected by quantitative real-time polymerase chain reaction and Western blot. The role of miR-455 in cell death caused by oxygen–glucose deprivation (OGD) was assessed using Cell Counting Kit-8 (CCK-8) assay. The influence of miR-455 on infarct volume was evaluated in mouse brain after middle cerebral artery occlusion (MCAO). Bioinformatics softwares and luciferase analysis were used to find and confirm the targets of miR-455. The results showed that the expression levels of miR-455 significantly decreased in primary neuronal cells subjected to OGD and mouse brain subjected to MCAO. In addition, forced expression of miR-455 inhibited neuronal death and weakened ischemic brain infarction in focal ischemia-stroked mice. Furthermore, TRAF3 was proved to be a direct target of miR-455, and miR-455 could negatively suppress TRAF3 expression. Biological function analysis showed that TRAF3 silencing displayed the neuroprotective effect in ischemic stroke and could enhance miR-455-induced positive impact on ischemic injury both in vitro and in vivo. Taken together, miR-455 played a vital role in protecting neuronal cells from death by downregulating TRAF3 protein expression. These findings may represent a novel latent therapeutic target for cerebral ischemic stroke.Keywords
This publication has 30 references indexed in Scilit:
- Downregulation of miR-181b in mouse brain following ischemic stroke induces neuroprotection against ischemic injury through targeting heat shock protein A5 and ubiquitin carboxyl-terminal hydrolase isozyme L1Journal of Neuroscience Research, 2013
- Roles for MicroRNAs in Conferring Robustness to Biological ProcessesCell, 2012
- Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cellsOncogene, 2012
- Temporal Differences in MicroRNA Expression Patterns in Astrocytes and Neurons after Ischemic InjuryPLOS ONE, 2011
- MicroRNA-210 as a Novel Therapy for Treatment of Ischemic Heart DiseaseCirculation, 2010
- Mammalian microRNAs predominantly act to decrease target mRNA levelsNature, 2010
- Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34Cancer Research, 2010
- MicroRNAs as Effectors of Brain Function with Roles in Ischemia and Injury, Neuroprotection, and NeurodegenerationJournal of Cerebral Blood Flow & Metabolism, 2010
- miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemiaNeurobiology of Disease, 2010
- Neuroprotective strategies targeting apoptotic and necrotic cell death for strokeApoptosis, 2009